OTC Markets OTCPK - Delayed Quote • USD GlobeStar Therapeutics Corporation (GSTC) Follow Compare 0.0003 +0.0000 +(16.67%) At close: January 10 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Globestar Therapeutics Update on Project Amethyst(TM) and Recent Financials RICHLAND, WA / ACCESSWIRE / March 28, 2024 / GlobeStar Therapeutics Corporation (OTC PINK:GSTC) (GSTC), is a clinical stage pharmaceutical company focused on advancing new therapies for Multiple Sclerosis (MS) and other neurological diseases, including ... Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return GSTC S&P 500 YTD +16.67% -1.35% 1-Year -70.83% +22.51% 3-Year -97.88% +24.59%